Source link : https://www.newshealth.biz/health-news/eu-oks-meningococcal-disease-vaccine/
During its September 2024 meeting, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the go-ahead for Penbraya (Pfizer) — meningococcal groups A, C, W, Y conjugate and group B vaccine — to be used to protect individuals from invasive meningococcal disease. The pentavalent vaccine is indicated for active immunization […]
Author : News Health
Publish date : 2024-09-20 17:51:02
Copyright for syndicated content belongs to the linked Source.
